SI
RNAM

Sofinnova Investments’s Avidity Biosciences RNAM Stock Holding History

Sofinnova Investments’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-745,116
Closed -$53.7M – 87
2025
Q4 		$53.7M Sell
745,116
-130,809
-15% -$8.45M 2.32% 14
2025
Q3 		$38.2M Buy
875,925
+291,124
+50% +$11.8M 2.09% 18
2025
Q2 		$16.6M Buy
584,801
+204,870
+54% +$6.11M 1.02% 31
2025
Q1 		$11.2M Buy
379,931
+366,142
+2,655% +$11.4M 0.73% 36
2024
Q4 		$401K Sell
13,789
-16,683
-55% -$697K 0.03% 61
2024
Q3 		$1.4M Buy
30,472
+9,047
+42% +$393K 0.11% 54
2024
Q2 		$875K Buy
+21,425
New +$615K 0.05% 71

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Sofinnova Investments's RNAM Position: Q1 2026 in Review

Sofinnova Investments sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 745,116 shares — an estimated $53.7M sold.

Sofinnova Investments first reported a position in RNAM in Q2 2024 and held it in 7 quarters. The position peaked at $53.7M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Sofinnova Investments reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Sofinnova Investments sold 745,116 Avidity Biosciences shares in Q1 2026, an estimated $53.7M.
  • Sofinnova Investments first reported a position in Avidity Biosciences in Q2 2024 and held it in 7 quarters.
  • Sofinnova Investments's Avidity Biosciences position peaked at $53.7M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Sofinnova Investments's 13F filing for Q1 2026, filed 15 May 2026.